| Ytd | -53.84% | |
| 1y | -40.69% |
| Open | 4.83 | Prev Close | 4.85 | Low | 4.75 | High | 4.94 | Mkt Cap | 200.06M |
| Vol | 522.34K | Avg Vol | 862.64K | EPS | -1.13 | P/E | N/A | Forward P/E | -49.73 |
| Beta | 1.22 | Short Ratio | 4.55 | Inst. Own | 91.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 5.91 | 200-d Avg | 6.81 | 1yr Est | 41.90 |
RXST News
RxSight (NASDAQ: RXST - Get Free Report) and Bioventus (NASDAQ: BVS - Get Free Report) are both smal
RxSight (NASDAQ: RXST - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are b
Cerus (NASDAQ: CERS - Get Free Report) and RxSight (NASDAQ: RXST - Get Free Report) are both small-c
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and low
Corient Private Wealth LP bought a new stake in shares of RxSight, Inc. (NASDAQ: RXST) during the se
BlackRock Inc. acquired a new stake in RxSight, Inc. (NASDAQ: RXST) during the second quarter, accor
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price targe
RxSight (NASDAQ: RXST - Get Free Report) and Futureworld (OTCMKTS:FWDG - Get Free Report) are both h
UBS analyst Patrick Wood maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price targ
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight NASDAQ: RXST reported second-quarter revenue of $33.7 million, including $6.5 million recogn
RxSight (NASDAQ: RXST) reported second-quarter revenue of $33.7 million, including $6.5 million reco
RxSight, Inc. (RXST) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Es
ALISO VIEJO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported f
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earning
ALISO VIEJO, Calif. , July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The lat
RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026,
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surger
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on i
RxSight, Inc. exhibits quantitative similarities to other small caps that I have rated here on Seeki
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and low
U.S. stock futures were mixed on Tuesday, as the Dow Jones index rose while the Nasdaq 100 and S&
US stock futures trade lower, investors focus on PENG, RXST, SAR earnings, RIVN's public offerin
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
RxSight (NASDAQ:RXST) raises FY2026 sales outlook from $120.000 million-$135.000 million to $140.000
RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quar
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxS
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin